PUBLISHER: KBV Research | PRODUCT CODE: 1462065
PUBLISHER: KBV Research | PRODUCT CODE: 1462065
LAMEA HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030
The Latin America, Middle East and Africa HIV Injection Market would witness market growth of 19.8% CAGR during the forecast period (2023-2030).
The Brazil market dominated the LAMEA HIV Injection Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $52.8 Million by 2029. The Argentina market is showcasing a CAGR of 20.7% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 19.4% during (2023 - 2030).
Studies have shown that adherence to oral antiretroviral therapy can be challenging for some patients, leading to suboptimal treatment outcomes and an increased risk of developing drug resistance. Injectable treatments, by contrast, are administered by healthcare providers, which can help ensure that patients receive their medications as prescribed. This can be especially important for patients who may struggle with adherence or who may be at risk of forgetting to take their medications.
The development of new antiretroviral drugs and treatment regimens has expanded the options available for injectable treatments, providing patients with more effective and convenient treatment options. One of the key advancements in HIV treatment has been the development of long-acting injectable therapies. These medications are administered less frequently than traditional oral medications, ranging from once a week to once every few months, depending on the specific drug.
Sub-Saharan Africa is classified as the region with the highest prevalence rates of HIV/AIDS on a global scale, with certain countries within the area bearing the brunt of this burden. For example, countries in southern Africa, such as South Africa, Swaziland, and Lesotho, have among the highest prevalence rates in the world. Hence, all of these factors will significantly support the expansion of the market in this region.
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F. Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
LAMEA HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1LAMEA HIV Injection Market, by Distribution Channel
- 1.4.2LAMEA HIV Injection Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.LAMEA HIV Injection Market by Distribution Channel
- 4.1LAMEA Hospital Pharmacy Market by Country
- 4.2LAMEA Drugs Stores & Retail Pharmacies Market by Country
- 4.3LAMEA Others Market by Country
Chapter 5.LAMEA HIV Injection Market by Country
- 5.1Brazil HIV Injection Market
- 5.1.1Brazil HIV Injection Market by Distribution Channel
- 5.2Argentina HIV Injection Market
- 5.2.1Argentina HIV Injection Market by Distribution Channel
- 5.3UAE HIV Injection Market
- 5.3.1UAE HIV Injection Market by Distribution Channel
- 5.4Saudi Arabia HIV Injection Market
- 5.4.1Saudi Arabia HIV Injection Market by Distribution Channel
- 5.5South Africa HIV Injection Market
- 5.5.1South Africa HIV Injection Market by Distribution Channel
- 5.6Nigeria HIV Injection Market
- 5.6.1Nigeria HIV Injection Market by Distribution Channel
- 5.7Rest of LAMEA HIV Injection Market
- 5.7.1Rest of LAMEA HIV Injection Market by Distribution Channel
Chapter 6.Company Profiles
- 6.1GlaxoSmithKline PLC (GSK)
- 6.1.1Company Overview
- 6.1.2Financial Analysis
- 6.1.3Regional Analysis
- 6.1.4Research & Development Expense
- 6.1.5SWOT Analysis
- 6.1Gilead Sciences, Inc.
- 6.1.1Company overview
- 6.1.2Financial Analysis
- 6.1.3Research & Development Expenses
- 6.1.4SWOT Analysis
- 6.2ImmunityBio, Inc.
- 6.2.1Company Overview
- 6.2.2Financial Analysis
- 6.2.3Regional Analysis
- 6.2.4Research & Development Expenses
- 6.2.5SWOT Analysis
- 6.3F. Hoffmann-La Roche Ltd.
- 6.3.1Company Overview
- 6.3.2Financial Analysis
- 6.3.3Segmental and Regional Analysis
- 6.3.4Research & Development Expense
- 6.3.5SWOT Analysis
- 6.4Theratechnologies Inc.
- 6.4.1Company Overview
- 6.4.2Financial Analysis
- 6.4.3Research & Development Expenses
- 6.4.4SWOT Analysis
- 6.5Viriom, Inc.
- 6.5.1Company Overview
- 6.5.2SWOT Analysis
- 6.6AbbVie, Inc.
- 6.6.1Company Overview
- 6.6.2Financial Analysis
- 6.6.3Regional Analysis
- 6.6.4Research & Development Expense
- 6.6.5SWOT Analysis
- 6.7Brii Biosciences Limited
- 6.7.1Company Overview
- 6.7.2Financial Analysis
- 6.7.3Research & Development Expenses
- 6.7.4SWOT Analysis
- 6.8Shionogi & Co., Ltd.
- 6.8.1Company Overview
- 6.8.2Financial Analysis
- 6.8.3Research & Development Expenses
- 6.8.4SWOT Analysis
- 6.9Boehringer Ingelheim International GmbH
- 6.9.1Company Overview
- 6.9.2Financial Analysis
- 6.9.3Regional & Segmental Analysis
- 6.9.4Research & Development Expenses
- 6.9.5SWOT Analysis
LIST OF TABLES
- TABLE 1LAMEA HIV Injection Market, 2019 - 2022, USD Million
- TABLE 2LAMEA HIV Injection Market, 2023 - 2030, USD Million
- TABLE 3LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 4LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 5LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 6LAMEA Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 7LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 8LAMEA Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 9LAMEA Others Market by Country, 2019 - 2022, USD Million
- TABLE 10LAMEA Others Market by Country, 2023 - 2030, USD Million
- TABLE 11LAMEA HIV Injection Market by Country, 2019 - 2022, USD Million
- TABLE 12LAMEA HIV Injection Market by Country, 2023 - 2030, USD Million
- TABLE 13Brazil HIV Injection Market, 2019 - 2022, USD Million
- TABLE 14Brazil HIV Injection Market, 2023 - 2030, USD Million
- TABLE 15Brazil HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 16Brazil HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 17Argentina HIV Injection Market, 2019 - 2022, USD Million
- TABLE 18Argentina HIV Injection Market, 2023 - 2030, USD Million
- TABLE 19Argentina HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 20Argentina HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 21UAE HIV Injection Market, 2019 - 2022, USD Million
- TABLE 22UAE HIV Injection Market, 2023 - 2030, USD Million
- TABLE 23UAE HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 24UAE HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 25Saudi Arabia HIV Injection Market, 2019 - 2022, USD Million
- TABLE 26Saudi Arabia HIV Injection Market, 2023 - 2030, USD Million
- TABLE 27Saudi Arabia HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 28Saudi Arabia HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 29South Africa HIV Injection Market, 2019 - 2022, USD Million
- TABLE 30South Africa HIV Injection Market, 2023 - 2030, USD Million
- TABLE 31South Africa HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 32South Africa HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 33Nigeria HIV Injection Market, 2019 - 2022, USD Million
- TABLE 34Nigeria HIV Injection Market, 2023 - 2030, USD Million
- TABLE 35Nigeria HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 36Nigeria HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 37Rest of LAMEA HIV Injection Market, 2019 - 2022, USD Million
- TABLE 38Rest of LAMEA HIV Injection Market, 2023 - 2030, USD Million
- TABLE 39Rest of LAMEA HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 40Rest of LAMEA HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 41Key Information - GlaxoSmithKline PLC
- TABLE 42Key Information - Gilead Sciences, Inc.
- TABLE 43Key Information - ImmunityBio, Inc.
- TABLE 44Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 45Key Information - Theratechnologies Inc.
- TABLE 46Key Information - Viriom, Inc.
- TABLE 47Key information - AbbVie, Inc.
- TABLE 48Key Information - Brii Biosciences Limited
- TABLE 49Key Information - Shionogi & Co., Ltd.
- TABLE 50Key Information - Boehringer Ingelheim International GmbH
